1. Role of Non-Statins, LDL-C Thresholds, and Special Population Considerations: A Look at the Updated 2016 ACC Consensus Committee Recommendations

   • Bhavin B. Adhyaru
   • Terry A. Jacobson

   STATIN DRUGS (B. WIGGINS, SECTION EDITOR) 12 May 2017 Article: 29

2. The Role of Emerging Risk Factors in Cardiovascular Outcomes

   • Ben Lacey
   • William G. Herrington
   • Jane Armitage

   Evidence Based Medicine (L. Roever, Section Editor) Open access 06 May 2017 Article: 28

   

3. Role of Inflammation in Heart Failure

   • Lily F. Shirazi
   • Joe Bissett
   • Jawahar L. Mehta

   Evidence Based Medicine (L. Roever, Section Editor) 21 April 2017 Article: 27

   

4. What is the Current Knowledge About the Cardiovascular Risk for Users of Cannabis-Based Products? A Systematic Review

   • Emilie Jouanjus
   • Valentin Raymond
   • Valérie Wolff

   Coronary Heart Disease (S. Virani and S. Naderi, Section Editors) 21 April 2017 Article: 26

   

5. Overview of Coronary Heart Disease Risk Initiatives in South Asia

   • Ankur Kalra
   • Deepak L. Bhatt
   • Salim S. Virani

   Global Coronary Heart Disease (S. Virani and S. Naderi, Section Editors) 17 April 2017 Article: 25